Your browser doesn't support javascript.
loading
Azelnidipine treatment reduces the expression of Cav1.2 protein.
Nasu, Fumiaki; Obara, Yutaro; Okamoto, Yosuke; Yamaguchi, Hiroaki; Kurakami, Kazuya; Norota, Ikuo; Ishii, Kuniaki.
Afiliação
  • Nasu F; Department of Pharmacology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan; Yamagata Prefectural Central Hospital, Yamagata 990-2292, Japan.
  • Obara Y; Department of Pharmacology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
  • Okamoto Y; Department of Cell Physiology, Akita University Graduate School of Medicine, 010-0825, Japan.
  • Yamaguchi H; Department of Pharmacy, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
  • Kurakami K; Department of Pharmacology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan; Department of Head and Neck Surgery, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
  • Norota I; Department of Pharmacology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
  • Ishii K; Department of Pharmacology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan. Electronic address: kuishii@med.id.yamagata-u.ac.jp.
Life Sci ; 269: 119043, 2021 Mar 15.
Article em En | MEDLINE | ID: mdl-33453240
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article